Immunohistochemical Versus Molecular (blueprint and MammaPrint) Subtyping of Breast Carcinoma. Outcome Results from the EORTC 10041/BIG 3-04 MINDACT Trial.

G. Viale,F. A. de Snoo,L. Slaets,J. Bogaerts,L. van ’t Veer,E. J. Rutgers,M. J. Piccart-Gebhart,L. Stork-Sloots,A. Glas,L. Russo,P. Dell’Orto,K. Tryfonidis,S. Litière,F. Cardoso, for the MINDACT investigators

Breast cancer research and treatment（2017）

引用 50|浏览57

暂无评分

关键词

Molecular subtypes,Breast cancer,Pathological subtyping

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要